Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wedbush Reiterates Outperform on Adicet Bio, Maintains $30 Price Target

Wedbush Reiterates Outperform on Adicet Bio, Maintains $30 Price Target

Wedbush analyst Robert Driscoll reiterates Adicet Bio (NASDAQ:ACET) with a Outperform and maintains $30 price target.

March 16, 2023

1 minute read

Wedbush analyst Robert Driscoll reiterates Adicet Bio (NASDAQ:ACET) with a Outperform and maintains $30 price target.

Volkswagen, BMW Battery Supplier Northvolt Eyes Raising $5B Via Debt

March 27, 8:46 AM

Volkswagen AG (OTC: VWAGY) and Bayerische Motoren Werke AG (OTC: BMWYY) battery supplier Northvolt weighed securing over $5 billion of financing.

May 3, 2:11 AM

Market commentator Jim Cramer reportedly said there are four main hurdles all investors have to navigate in current…

February 7, 12:00 AM

Tesla Inc (NASDAQ:TSLA) has cut prices on its costliest Model Y version in Canada, days after the company…

March 20, 12:21 PM

- Reuters